vs

Side-by-side financial comparison of Clearwater Analytics Holdings, Inc. (CWAN) and Zai Lab Ltd (ZLAB). Click either name above to swap in a different company.

Clearwater Analytics Holdings, Inc. is the larger business by last-quarter revenue ($217.5M vs $127.1M, roughly 1.7× Zai Lab Ltd). On growth, Clearwater Analytics Holdings, Inc. posted the faster year-over-year revenue change (72.0% vs 17.1%). Clearwater Analytics Holdings, Inc. produced more free cash flow last quarter ($52.3M vs $-26.7M). Over the past eight quarters, Clearwater Analytics Holdings, Inc.'s revenue compounded faster (45.5% CAGR vs 20.8%).

Clearwater Analytics Holdings, Inc. is an American software-as-a-service (SaaS) fintech company that provides automated investment accounting, performance, compliance, and risk reporting worldwide. Clearwater is a publicly traded company headquartered in Boise, Idaho, with additional offices in London, Edinburgh, New York City and Noida.

Zai Lab Ltd is a global biopharmaceutical company focused on developing, manufacturing and commercializing innovative therapies for oncology, autoimmune disorders, infectious diseases and other unmet medical needs. It operates primarily in the Greater China region and partners with leading global biotech firms to expand access to life-saving treatments for underserved patient populations.

CWAN vs ZLAB — Head-to-Head

Bigger by revenue
CWAN
CWAN
1.7× larger
CWAN
$217.5M
$127.1M
ZLAB
Growing faster (revenue YoY)
CWAN
CWAN
+54.8% gap
CWAN
72.0%
17.1%
ZLAB
More free cash flow
CWAN
CWAN
$79.0M more FCF
CWAN
$52.3M
$-26.7M
ZLAB
Faster 2-yr revenue CAGR
CWAN
CWAN
Annualised
CWAN
45.5%
20.8%
ZLAB

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CWAN
CWAN
ZLAB
ZLAB
Revenue
$217.5M
$127.1M
Net Profit
$-11.8M
Gross Margin
67.2%
51.0%
Operating Margin
-3.1%
-54.6%
Net Margin
-5.4%
Revenue YoY
72.0%
17.1%
Net Profit YoY
-102.8%
EPS (diluted)
$-0.04
$-0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CWAN
CWAN
ZLAB
ZLAB
Q4 25
$217.5M
$127.1M
Q3 25
$205.1M
$115.4M
Q2 25
$181.9M
$109.1M
Q1 25
$126.9M
$105.7M
Q4 24
$126.5M
$108.5M
Q3 24
$115.8M
$101.8M
Q2 24
$106.8M
$100.1M
Q1 24
$102.7M
$87.1M
Net Profit
CWAN
CWAN
ZLAB
ZLAB
Q4 25
$-11.8M
Q3 25
$-10.3M
$-36.0M
Q2 25
$-23.2M
$-40.7M
Q1 25
$6.5M
$-48.4M
Q4 24
$419.3M
Q3 24
$3.6M
$-41.7M
Q2 24
$-430.0K
$-80.3M
Q1 24
$1.9M
$-53.5M
Gross Margin
CWAN
CWAN
ZLAB
ZLAB
Q4 25
67.2%
51.0%
Q3 25
65.6%
59.5%
Q2 25
65.1%
60.6%
Q1 25
73.3%
63.6%
Q4 24
73.5%
61.5%
Q3 24
72.9%
64.1%
Q2 24
72.0%
64.9%
Q1 24
72.6%
61.4%
Operating Margin
CWAN
CWAN
ZLAB
ZLAB
Q4 25
-3.1%
-54.6%
Q3 25
3.2%
-42.3%
Q2 25
-8.0%
-50.3%
Q1 25
5.6%
-53.3%
Q4 24
1.0%
-62.6%
Q3 24
6.3%
-66.6%
Q2 24
3.6%
-76.0%
Q1 24
-0.2%
-80.7%
Net Margin
CWAN
CWAN
ZLAB
ZLAB
Q4 25
-5.4%
Q3 25
-5.0%
-31.2%
Q2 25
-12.8%
-37.3%
Q1 25
5.1%
-45.8%
Q4 24
331.5%
Q3 24
3.1%
-40.9%
Q2 24
-0.4%
-80.2%
Q1 24
1.8%
-61.4%
EPS (diluted)
CWAN
CWAN
ZLAB
ZLAB
Q4 25
$-0.04
$-0.05
Q3 25
$-0.04
$-0.03
Q2 25
$-0.09
$-0.04
Q1 25
$0.03
$-0.04
Q4 24
$1.65
$-0.09
Q3 24
$0.02
$-0.04
Q2 24
$0.00
$-0.08
Q1 24
$0.01
$-0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CWAN
CWAN
ZLAB
ZLAB
Cash + ST InvestmentsLiquidity on hand
$91.2M
$689.6M
Total DebtLower is stronger
$822.6M
Stockholders' EquityBook value
$2.0B
$715.5M
Total Assets
$3.0B
$1.2B
Debt / EquityLower = less leverage
0.41×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CWAN
CWAN
ZLAB
ZLAB
Q4 25
$91.2M
$689.6M
Q3 25
$64.1M
$717.2M
Q2 25
$71.9M
$732.2M
Q1 25
$282.9M
$757.3M
Q4 24
$255.5M
$779.7M
Q3 24
$305.8M
$616.1M
Q2 24
$257.9M
$630.0M
Q1 24
$267.6M
$650.8M
Total Debt
CWAN
CWAN
ZLAB
ZLAB
Q4 25
$822.6M
Q3 25
$838.9M
Q2 25
$878.1M
Q1 25
Q4 24
$43.3M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
CWAN
CWAN
ZLAB
ZLAB
Q4 25
$2.0B
$715.5M
Q3 25
$2.0B
$759.9M
Q2 25
$2.0B
$791.7M
Q1 25
$1.1B
$810.8M
Q4 24
$1.0B
$840.9M
Q3 24
$403.2M
$667.7M
Q2 24
$380.6M
$704.2M
Q1 24
$406.2M
$762.2M
Total Assets
CWAN
CWAN
ZLAB
ZLAB
Q4 25
$3.0B
$1.2B
Q3 25
$3.0B
$1.2B
Q2 25
$3.0B
$1.2B
Q1 25
$1.3B
$1.2B
Q4 24
$1.2B
$1.2B
Q3 24
$623.5M
$985.3M
Q2 24
$585.1M
$987.4M
Q1 24
$547.8M
$988.4M
Debt / Equity
CWAN
CWAN
ZLAB
ZLAB
Q4 25
0.41×
Q3 25
0.42×
Q2 25
0.45×
Q1 25
Q4 24
0.04×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CWAN
CWAN
ZLAB
ZLAB
Operating Cash FlowLast quarter
$55.3M
$-26.0M
Free Cash FlowOCF − Capex
$52.3M
$-26.7M
FCF MarginFCF / Revenue
24.0%
-21.0%
Capex IntensityCapex / Revenue
1.4%
0.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$164.3M
$-158.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CWAN
CWAN
ZLAB
ZLAB
Q4 25
$55.3M
$-26.0M
Q3 25
$49.0M
$-32.0M
Q2 25
$47.1M
$-31.0M
Q1 25
$24.5M
$-61.7M
Q4 24
$-29.2M
$-55.8M
Q3 24
$49.6M
$-26.8M
Q2 24
$43.9M
$-42.2M
Q1 24
$10.0M
$-90.1M
Free Cash Flow
CWAN
CWAN
ZLAB
ZLAB
Q4 25
$52.3M
$-26.7M
Q3 25
$44.9M
$-35.0M
Q2 25
$44.1M
$-33.9M
Q1 25
$23.0M
$-63.2M
Q4 24
$-30.0M
$-58.4M
Q3 24
$48.1M
$-28.2M
Q2 24
$42.4M
$-42.9M
Q1 24
$8.6M
$-91.1M
FCF Margin
CWAN
CWAN
ZLAB
ZLAB
Q4 25
24.0%
-21.0%
Q3 25
21.9%
-30.4%
Q2 25
24.2%
-31.1%
Q1 25
18.2%
-59.9%
Q4 24
-23.7%
-53.8%
Q3 24
41.5%
-27.7%
Q2 24
39.7%
-42.9%
Q1 24
8.4%
-104.5%
Capex Intensity
CWAN
CWAN
ZLAB
ZLAB
Q4 25
1.4%
0.5%
Q3 25
2.0%
2.6%
Q2 25
1.6%
2.6%
Q1 25
1.2%
1.5%
Q4 24
0.6%
2.4%
Q3 24
1.3%
1.3%
Q2 24
1.4%
0.7%
Q1 24
1.4%
1.1%
Cash Conversion
CWAN
CWAN
ZLAB
ZLAB
Q4 25
Q3 25
Q2 25
Q1 25
3.76×
Q4 24
-0.07×
Q3 24
13.66×
Q2 24
Q1 24
5.29×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CWAN
CWAN

Segment breakdown not available.

ZLAB
ZLAB

Zejula$56.0M44%
Other$21.9M17%
Nuzyra$16.0M13%
Optune$11.9M9%
XACDURO$10.7M8%
Qinlock$9.7M8%
AUGTYRO$836.0K1%

Related Comparisons